Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Jul;8(7):1159-67.
doi: 10.1586/14737140.8.7.1159.

Genetic polymorphisms and endometrial cancer risk

Larissa A Meyer  1 , Shannon N Westin, Karen H Lu, Michael R Milam
Affiliations
Review

Genetic polymorphisms and endometrial cancer risk

Larissa A Meyer et al. Expert Rev Anticancer Ther. 2008 Jul.

Abstract

For most sporadic cancers, genetic susceptibility results from the additive effect of multiple genetic variants, each of which contributes a modest risk individually. The study of genetic single nucleotide polymorphisms (SNPs) may help explain the differences in individual cancer susceptibility and may assist in identifying novel markers of risk that can be utilized to create more effective and tailored cancer prevention strategies. Genetic polymorphisms in functionally critical genes have been suggested as risk factors for the development of a variety of cancers, including endometrial cancer. Candidate SNPs may be involved in DNA damage repair, steroid metabolism, carcinogen metabolism, cell-cycle control, apoptosis and steroid receptor activation pathways. In this review, recent findings of genetic association studies exploring genetic polymorphisms and their association with endometrial cancer are reported. In addition, the challenges of genetic association studies, such as power and bias, and the need for validation of promising findings are explored.

PubMed Disclaimer

Conflict of interest statement

Financial & competing interests disclosure

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

No writing assistance was utilized in the production of this manuscript.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Jemal A, Siegel R, Ward E, et al. Cancer statistics 2008. CA Cancer J. Clin. 2008;58:71–96. - PubMed
    1. Sorosky JI. Endometrial cancer. Obstet. Gynecol. 2008;111:436–447. - PubMed
    1. Gruber SB, Thompson WD. A population- based study of endometrial cancer and familial risk in younger women. Cancer and Steroid Hormone Study Group. Cancer Epidemiol. Biomarkers Prev. 1996;5:411–417. - PubMed
    1. Smith DC, Prentice R, Thompson DJ, Herrmann WL. Association of exogenous estrogen and endometrial carcinoma. N. Engl. J. Med. 1975;293:1164–1167. - PubMed
    1. Ziel HK, Finkle WD. Increased risk of endometrial carcinoma among users of conjugated estrogens. N. Engl. J. Med. 1975;293:1167–1170. - PubMed

Websites

    1. Department of Health and Human Services. [Accessed February 22, 2008];Centers for Disease Control & Prevention. Overweight and Obesity. www.cdc.gov/nccdphp/dnpa/obesity/index.htm.
    1. Surveillance, Epidemiology and End Results (SEER) Program. DevCan database: Probability of Developing Cancer For Corpus and Uterus, NOS Cancer by Race, Females. SEER 17 Registries for 2002–2004. [Accessed February 22, 2008];NCI, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2006, based on November 2005 submission. www.seer.cancer.gov.